Genprex, Inc. (GNPX) income statement
GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.45−0.22 (-13.17%)
Close on Nov 20, 2026Market cap $1.19MP/E –Yield –
Genprex, Inc. financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $1.19MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Returns on capital | |||||||||||
| Return on equity | -338.7% | -473.4% | -207.9% | -74.7% | -57.2% | -105.7% | -179.0% | -265.8% | -322.8% | -409.4% | – |
| Return on assets | -227.2% | -285.4% | -172.6% | -69.9% | -55.7% | -102.8% | -166.4% | -235.0% | -209.1% | -216.3% | – |
| Return on tangible assets | -227.2% | -285.4% | -180.4% | -71.4% | -56.7% | -106.5% | -180.3% | -253.3% | -257.6% | -247.5% | – |
| Return on capital employed | -323.1% | -468.6% | -209.2% | -75.0% | -57.3% | -105.8% | -179.5% | -265.6% | -322.6% | -254.3% | – |
| NOPAT | -$12.26M | -$16.73M | -$24.53M | -$18.83M | -$16.33M | -$14.19M | -$8.44M | -$9.77M | -$2.62M | -$3.26M | – |
| Cash flow quality | |||||||||||
| OCF / Net income | 0.94 | 0.85 | 0.80 | 0.74 | 0.69 | 0.78 | 0.65 | 0.55 | 0.66 | 0.30 | – |
| FCF / OCF | – | – | – | 100.0% | 100.2% | 100.1% | 100.5% | 100.3% | 100.3% | 100.4% | – |
| FCF / Net income | – | – | – | 0.74 | 0.69 | 0.78 | 0.65 | 0.56 | 0.66 | 0.30 | – |
| Unlevered free cash flow | – | – | – | -$17.62M | -$14.32M | -$13.95M | -$6.95M | -$6.84M | -$2.18M | -$1.25M | – |
| Levered free cash flow | – | – | – | -$17.62M | -$14.32M | -$13.95M | -$6.95M | -$6.87M | -$2.18M | -$1.25M | – |
| Efficiency | |||||||||||
| Asset turnover | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | 0.00 | – |
| Fixed asset turnover | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | 0.00 | – |
| Receivables turnover | – | – | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | 0.00 | – |
| CapEx to OCF | – | – | – | -0.00% | -0.22% | -0.13% | -0.48% | -0.33% | -0.27% | -0.40% | – |
| Liquidity | |||||||||||
| Current ratio | 3.84 | 0.83 | 2.31 | 7.64 | 24.69 | 61.47 | 5.83 | 22.81 | 0.23 | 5.74 | – |
| Quick ratio | 3.84 | 0.83 | 2.31 | 7.64 | 24.69 | 61.47 | 5.83 | 22.81 | 0.23 | 5.74 | – |
| Cash ratio | 3.60 | 0.64 | 2.07 | 7.46 | 24.37 | 60.61 | 3.92 | 22.18 | 0.19 | 5.61 | – |
| Working capital | $6.18M | -$426.70K | $4.28M | $18.66M | $37.55M | $27.25M | $2.47M | $8.46M | -$637.39K | $1.35M | – |
| Net current asset value | $6.16M | -$426.70K | $4.28M | $18.66M | $37.55M | $27.25M | $2.47M | $8.46M | -$637.39K | $1.35M | – |
| Leverage | |||||||||||
| Assets to equity | 1.28 | 2.55 | 1.44 | 1.13 | 1.04 | 1.01 | 1.17 | 1.04 | 2.94 | 1.18 | – |
| Intangibles to total assets | – | 0.00% | 7.2% | 2.8% | 1.5% | 1.9% | 13.9% | 4.1% | 23.7% | 12.6% | – |
| Interest coverage | |||||||||||
| EBIT / Interest expense | – | – | – | – | – | – | – | -325.51 | -1,752.56 | – | – |
| Per share | |||||||||||
| Revenue per share | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | 0.00 | – |
| EPS (basic) | -17.40 | -266.89 | -1,128.00 | -990.00 | -880.00 | -1,020.00 | -1,320.00 | -1,800.00 | -580.00 | -760.00 | – |
| EPS (diluted) | – | – | – | – | -840.00 | -1,020.00 | -1,320.00 | -1,800.00 | -580.00 | -760.00 | – |
| Book value per share | 53.15 | 7.46 | 249.56 | 926.03 | 1,724.40 | 1,434.04 | 313.91 | 1,165.50 | 73.12 | 285.97 | – |
| Tangible book value per share | 53.15 | 7.46 | 223.53 | 896.84 | 1,697.57 | 1,406.14 | 262.91 | 1,115.71 | 22.18 | 243.55 | – |
| Cash per share | 52.27 | 7.37 | 226.72 | 871.13 | 1,613.77 | 1,267.21 | 207.90 | 1,128.73 | 27.51 | 281.99 | – |
| Operating cash flow per share | -102.20 | -82.50 | -832.45 | -732.58 | -596.77 | -646.37 | -718.31 | -898.50 | -370.52 | -219.69 | – |
| Free cash flow per share | – | – | – | -732.58 | -598.10 | -647.18 | -721.77 | -901.44 | -371.52 | -220.56 | – |
| CapEx per share | – | – | – | 0.00 | 1.32 | 0.81 | 3.46 | 2.94 | 1.00 | 0.88 | – |
| Valuation at period end | |||||||||||
| Market cap | $38.67M | $102.85M | $300.75M | $1.53B | $1.38B | $3.60B | $111.54M | $364.78M | – | – | – |
| Enterprise value | $37.56M | $101.36M | $289.03M | $1.51B | $1.34B | $3.58B | $108.99M | $354.47M | – | – | – |
| P/B | 4.9x | 63.5x | 40.6x | 68.8x | 33.4x | 117x | 36.9x | 41.1x | – | – | – |
| P/TBV | 4.9x | 63.5x | 45.3x | 71.0x | 33.9x | 119x | 44.0x | 42.9x | – | – | – |
| P/OCF | -2.5x | -5.7x | -12.2x | -86.9x | -96.5x | -259x | -16.1x | -53.3x | – | – | – |
| EV/OCF | -2.5x | -5.7x | -11.7x | -85.5x | -93.5x | -257x | -15.8x | -51.8x | – | – | – |
| Earnings yield | -42.0% | -20.5% | -10.3% | -1.5% | -1.5% | -0.50% | -9.6% | -3.4% | – | – | – |
| FCF yield | – | – | – | -1.2% | -1.0% | -0.39% | -6.2% | -1.9% | – | – | – |
| Per employee | |||||||||||
| Total employees | 13 | 15 | 26 | 28 | 17 | 12 | 8 | 7 | 4 | 4 | 4 |
| Revenue per employee | – | – | – | $0 | $0 | $0 | – | $0 | $0 | $0 | – |
| Operating profit per employee | -$1.19M | -$1.41M | -$1.19M | -$851.10K | -$1.22M | -$1.50M | -$1.34M | -$1.77M | -$828.09K | -$1.03M | – |
| Net income per employee | -$1.25M | -$1.41M | -$1.19M | -$847.88K | -$1.22M | -$1.50M | -$1.33M | -$1.77M | -$828.54K | -$1.03M | – |
| Free cash flow per employee | – | – | – | -$629.34K | -$842.15K | -$1.16M | -$869.01K | -$981.28K | -$544.37K | -$313.31K | – |
| Growth | |||||||||||
| EBIT 1Y growth | 26.7% | 31.8% | -30.3% | -15.3% | -15.1% | -68.1% | 13.6% | -273.3% | 19.8% | – | – |
| Net income 1Y growth | 23.1% | 31.6% | -30.0% | -14.9% | -15.2% | -68.4% | 13.9% | -273.3% | 19.8% | – | – |
| Diluted EPS 1Y growth | – | – | – | – | 17.6% | 22.7% | 26.7% | -210.3% | 23.7% | – | – |
| Operating cash flow 1Y growth | 14.6% | 27.6% | -40.4% | -23.4% | -2.5% | -101.4% | -1.1% | -215.3% | -74.0% | – | – |
| Free cash flow 1Y growth | – | – | – | -23.1% | -2.6% | -100.7% | -1.2% | -215.5% | -73.7% | – | – |
| CapEx 1Y growth | – | – | – | -100.0% | 80.5% | -47.4% | 48.7% | 281.0% | 18.3% | – | – |
| CapEx 3Y CAGR | – | – | – | – | 12.2% | 43.9% | 88.6% | – | – | – | – |
| CapEx 5Y CAGR | – | – | – | – | 44.8% | – | – | – | – | – | – |
| Total assets 1Y growth | 146.3% | -61.3% | -57.5% | -41.5% | 36.6% | 787.5% | -61.9% | 635.9% | -34.1% | – | – |
| Total assets 3Y CAGR | -26.0% | -54.2% | -30.2% | 92.2% | 66.6% | 192.0% | 22.8% | – | – | – | – |
| Total assets 5Y CAGR | -20.2% | 3.1% | 2.9% | 81.9% | 86.3% | – | – | – | – | – | – |
| Total equity 1Y growth | 391.4% | -78.2% | -66.7% | -46.0% | 33.5% | 922.5% | -66.0% | 1,972.3% | -73.6% | 312.7% | – |
| Total equity 3Y CAGR | -29.0% | -66.0% | -37.9% | 94.6% | 66.9% | 316.3% | 23.0% | 182.5% | – | – | – |
| Total equity 5Y CAGR | -23.8% | -11.7% | -3.5% | 120.4% | 91.0% | 139.3% | – | – | – | – | – |
| Total equity 10Y CAGR | 35.1% | – | – | – | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.